Carcinoid Syndrome - Pipeline Insight, 2021
SKU ID :DEL-17687661 | Published Date: 15-Mar-2021 | No. of pages: 60Description
TOC
Introduction
Executive Summary
Carcinoid Syndrome: Overview
• Causes
• Mechanism of Action
• Signs and Symptoms
• Diagnosis
• Disease Management
Pipeline Therapeutics
• Comparative Analysis
Therapeutic Assessment
• Assessment by Product Type
• Assessment by Stage and Product Type
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
Carcinoid Syndrome – DelveInsight’s Analytical Perspective
In-depth Commercial Assessment
• Carcinoid Syndrome companies’ collaborations, Licensing, Acquisition -Deal Value Trends
Carcinoid Syndrome Collaboration Deals
• Company-Company Collaborations (Licensing / Partnering) Analysis
• Company-University Collaborations (Licensing / Partnering) Analysis
Early Stage Products (Phase I)
• Comparative Analysis
Paltusotine: Crinetics Pharmaceuticals
• Product Description
• Research and Development
• Product Development Activities
Drug profiles in the detailed report…..
Preclinical Stage Products
• Comparative Analysis
AQST-305: Aquestive Therapeutics
• Product Description
• Research and Development
• Product Development Activities
Drug profiles in the detailed report…..
Inactive Products
• Comparative Analysis
Carcinoid Syndrome Key Companies
Carcinoid Syndrome Key Products
Carcinoid Syndrome- Unmet Needs
Carcinoid Syndrome- Market Drivers and Barriers
Carcinoid Syndrome- Future Perspectives and Conclusion
Carcinoid Syndrome Analyst Views
Carcinoid Syndrome Key Companies
Appendix
Tables & Figures
Table 1 Total Products for Carcinoid Syndrome
Table 2 Late Stage Products
Table 3 Mid Stage Products
Table 4 Early Stage Products
Table 5 Pre-clinical & Discovery Stage Products
Table 6 Assessment by Product Type
Table 7 Assessment by Stage and Product Type
Table 8 Assessment by Route of Administration
Table 9 Assessment by Stage and Route of Administration
Table 10 Assessment by Molecule Type
Table 11 Assessment by Stage and Molecule Type
Table 12 Inactive Products
Companies
• Aquestive Therapeutics
• Crinetics Pharmaceuticals
- PRICE
-
$1500$4500